Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Eclipse Aesthetics Runs Afoul Of FDA Again For Uncleared Beauty Device

This article was originally published in The Rose Sheet

Executive Summary

Following an October 2015 warning letter for marketing an FDA-cleared medical device for unapproved cosmetic indications, Eclipse is targeted for marketing its MicroPen Elite micro-needling device as a safe alternative to other skin-resurfacing techniques without required premarket authorization.


Related Content

FDA: Cosmetic Warning Letters Carry Same Weight Regardless Of Issuing Office
Skarp Laser Razor’s Journey To Market Not Quite Light Speed





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts